Notably, we found that the WISP1 rs62514004 (AG + GG) and rs16893344 (CT + TT) genetic variants were associated with lower risks of greater tumor size and reaching a later clinical stage (Tables 3 and 4). The gene discussed is CCN4; the disease is neoplasm.